BrainsWay Ltd. (TLV:BWAY)
3,869.00
-154.00 (-3.83%)
At close: Mar 9, 2026
BrainsWay Market Cap
BrainsWay has a market cap or net worth of 1.58 billion as of March 9, 2026. Its market cap has increased by 119.19% in one year.
Market Cap
1.58B
Enterprise Value
1.37B
Revenue
162.56M
Ranking
n/a
PE Ratio
95.01
Stock Price
3,869.00
Market Cap Chart
Since September 24, 2007, BrainsWay's market cap has increased from 101.45M to 1.58B, an increase of 1,455.37%. That is a compound annual growth rate of 16.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 111.71B |
| Danel (Adir Yeoshua) | 2.83B |
| Kamada | 1.62B |
| SofWave Medical | 1.33B |
| Bait Bakfar | 1.05B |
| Ilex Medical | 670.95M |
| Novolog (Pharm-Up 1966) | 618.16M |
| Bonus BioGroup | 512.72M |